References
- Volkow ND , ChangL, WangGJ et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am. J. Psychiatry 158(12) , 2015–2021 (2001).
- Morita Y , UjikeH, TanakaY et al. A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia. Neurosci. Lett. 376(3) , 182–187 (2005)
- Chiang KP , GerberAL, SipeJC, CravattBF. Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use. Hum. Mol. Genet.13(18) , 2113–2119 (2004).
- Patricelli MP , CravattBF. Fatty acid amide hydrolase competitively degrades bioactive amides and esters through a nonconventional catalytic mechanism. Biochemistry38(43) , 14125–14130 (1999).
- McKinney MK , CravattBF. Structure and function of fatty acid amide hydrolase. Annu. Rev. Biochem.74 , 411–432 (2005).
- Cravatt BF , LichtmanAH. The endogenous cannabinoid system and its role in nociceptive behavior. J. Neurobiol.61(1) , 149–160 (2004).
- Cravatt BF , DemarestK, PatricelliMP et al. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl Acad. Sci. USA 98(16) , 9371–9376 (2001).
- Boger DL , SatoH, LernerAE et al. Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide. Proc. Natl Acad. Sci. USA 97(10) , 5044–5049 (2000).
- Lichtman AH , LeungD, SheltonCC et al. Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity. J. Pharmacol. Exp. Ther. 311(2) , 441–448 (2004).
- Jayamanne A , GreenwoodR, MitchellVA, AslanS, PiomelliD, VaughanCW. Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models. Br. J. Pharmacol.147(3) , 281–288 (2006).
- Sipe JC . The brain endogenous cannabinoid sysem: a role in reward/craving of addiction? Med. Hypotheses Res.1 , 1–10 (2004).
- Flanagan JM , GerberAL, CadetJL, BeutlerE, SipeJC. The fatty acid amide hydrolase 385 A/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction. Hum. Genet.120(4) , 581–588 (2006).
- Sipe JC , ChiangK, GerberAL, BeutlerE, CravattBF. A missense mutation in human fatty acid amide hydrolase associated with problem drug use. Proc. Natl Acad. Sci. USA99(12) , 8394–8399 (2002).
- Haughey HM , MarshallE, SchachtJP, LouisA, HutchisonKE. Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes. Addiction103(10) , 1678–1686 (2008).
- Schacht JP , SellingRE, HutchisonKE. Intermediate cannabis dependence phenotypes and the FAAH C385A variant: an exploratory analysis. Psychopharmacology (Berl.)203(3) , 511–517 (2009).
- Filbey FM , SchachtJP, MyersUS, ChavezRS, HutchisonKE. Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues. Neuropsychopharmacology35(4) , 967–975 (2010).
- Proudnikov D , KroslakT, SipeJC et al. Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes with heroin addiction: impact of long repeats of CNR1. Pharmacogenomics J. 10(3) , 232–242 (2010).
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th Edition). American Psychiatric Press, Washington, DC, USA (1994).
- Sim MS , MohamedZ, HatimA, Rajagopal Vl, Habil Mh. Association of brain-derived neurotrophic factor (Val66Met) genetic polymorphism with methamphetamine dependence in a Malaysian population. Brain Res.1357 , 91–96 (2010).
- Sheehan DV , LecrubierY, Sheehan Kh et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry59(Suppl. 20) , 22–33; quiz 34–57 (1998).
- Gordon D , FinchSJ, NothnagelM, OttJ. Power and sample size calculations for case–control genetic association tests when errors are present: application to single nucleotide polymorphisms. Hum. Hered.54(1) , 22–33 (2002).
- Gordon D , LevenstienMA, FinchSJ, OttJ. Errors and linkage disequilibrium interact multiplicatively when computing sample sizes for genetic case–control association studies. Pac. Symp. Biocomput.490–501 (2003).
- Agrawal A , LynskeyMT. Candidate genes for cannabis use disorders: findings, challenges and directions. Addiction104(4) , 518–532 (2009).
- Hatin WI , Nur-ShafawatiAR, ZahriMK et al. Population genetic structure of peninsular Malaysia Malay sub-ethnic groups. PLoS ONE 6(4) , e18312 (2011).
- Hock SS . Chinese migration. In: The Population of Malaysia. ISEAS Publishing, Pasir Panjang, Singapore (2007).
- Zeng J , LiJ, HuangG. 385 C/A polymorphism of the fatty acid amide hydrolase gene is associated with metabolic syndrome in the Chinese Han population. Arch. Med. Sci.7(3) , 423–427 (2011).
- Camilleri M , CarlsonP, McKinzieS et al. Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation. Am. J. Physiol. Gastrointest. Liver Physiol. 294(1) , G13–G19 (2008).
▪ Websites
- United Nations Information Service, UNIS: Launch of 2005 World Drug Report. www.unis.unvienna.org/unis/en/pressconf/2005/pb20050629.html2005
- United Nations Office on Drugs and Crime, UNODC: World Drug Report 2011. www.unodc.org/unodc/en/data)and)analysis/WDR)2011.html
- National Anti-Drug Agency: January – October 2010 Drug Report. Kuala Lumpur, Malaysia: Ministry of Home Affairs. www.adk.gov.my/html/laporandadah/Oktober%202010.pdf